Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Combined Single Dose Study Under Fasting Condition And Multiple Doses Study Under Normal Diabetic Meal Comparing the Bioavailability of Two Formulations of 500 mg Metformin Hydrochloride Extended Release Tablets.

NCT01677260 is registered in ClinicalTrials.gov with Dexa Medica Group as lead sponsor.

NCT NCT01677260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01677260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Combined Single Dose Study Under Fasting Condition And Multiple Doses Study Under Normal Diabetic Meal Comparing the Bioavailability of Two Formulations of 500 mg Metformin Hydrochloride Extended Release Tablets.
Lead sponsor
Dexa Medica Group
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2009
Completion date
January 31, 2010
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metformin xr be study in healthy volunteers with single and multiple dose